Amy Rasmussen
About Amy Rasmussen
Amy Rasmussen serves as the Executive Director of Clinical Operations at Alpine Immune Sciences, Inc., bringing extensive experience in clinical operations and regulatory science. She has held significant roles at various biotech companies, contributing to the development of over 10 products that received regulatory approval.
Work at Alpine Immune Sciences
Amy Rasmussen serves as the Executive Director of Clinical Operations at Alpine Immune Sciences, Inc. since 2023. In this role, she oversees clinical operations and contributes to the strategic direction of the company. Her responsibilities include managing clinical trials and ensuring compliance with regulatory standards. Rasmussen's extensive background in clinical operations supports her leadership in advancing the company's objectives in the biotechnology sector.
Previous Experience in Clinical Operations
Prior to her current role, Amy Rasmussen held significant positions in clinical operations at various organizations. She worked as the Senior Director of Clinical Operations at Atara Biotherapeutics from 2019 to 2021. Before that, she spent 21 years at Amgen as a Director, where she gained extensive experience in the biotechnology field. Most recently, she served as Senior Director of Clinical Operations at Turning Point Therapeutics from 2021 to 2023, further enhancing her expertise in the industry.
Education and Expertise
Amy Rasmussen has a strong educational background in health sciences and regulatory science. She earned a Master of Public Health in Health Sciences from UCLA, studying from 2000 to 2002. Additionally, she studied Regulatory Science at the University of Southern California for 11 months in 2009. Rasmussen also holds a Bachelor's degree in Sociology from Mills College, which she completed in 1994. Her education complements her broad therapeutic area experience in clinical operations.
Achievements in Product Development
Throughout her career, Amy Rasmussen has contributed to the successful development of over 10 biotech and pharmaceutical products that received regulatory approval. Her involvement in these projects showcases her capability in navigating complex regulatory environments. Additionally, she has participated in FDA advisory committee meetings, where she contributed to regulatory discussions and decisions, further highlighting her expertise in the field.
Leadership and Team Management Skills
Amy Rasmussen possesses strong leadership capabilities, demonstrated through her skills in building, leading, coaching, and managing teams. Her experience in setting up department infrastructure includes the development of standard operating procedures (SOPs) and processes, which enhances her effectiveness in clinical operations. Her ability to lead teams is a key aspect of her professional profile.